• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期血液透析幸存者的临床及透析相关特征:三例病例报告

Clinical and dialysis-related characteristics of extremely long-term hemodialysis survivors: Three case reports.

作者信息

Malgaj Vrečko Marija, Ponikvar Rafael, Gubenšek Jakob, Buturović Ponikvar Jadranka

机构信息

Center for Acute and Complicated Dialysis, Department of Nephrology, University Medical Center Ljubljana, Ljubljana, Slovenia.

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

出版信息

Hemodial Int. 2021 Mar 21;25(3):E29-32. doi: 10.1111/hdi.12925.

DOI:10.1111/hdi.12925
PMID:33749104
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8359961/
Abstract

More than 40-year hemodialysis survivors are living evidence of the achievements of hemodialysis therapy. We present the case reports of three patients treated by chronic hemodialysis for 47 (Patient 1), 43 (Patient 2), and 42 years (Patient 3) from a single center. These patients possess characteristics that were already shown to be associated with improved long-term survival: initiation of hemodialysis at a young age, absence of diabetes, and a relatively low and stable body weight with good nutritional status. Although all of them underwent complications of long-term hemodialysis treatment, they lived (Patient 3), or are still living (Patients 1 and 2), an independent and full life. Their hemodialysis prescriptions included long sessions with a moderate blood flow rate, state-of-the-art hemodialysis technology, vascular access surgeries and care provided by nephrologists, good overall management of chronic kidney disease, and preventive measures and/or immediate action in case of cardiovascular disease.

摘要

超过40年的血液透析幸存者是血液透析疗法取得成就的活生生的证据。我们呈现了来自单一中心的3例接受慢性血液透析治疗47年(患者1)、43年(患者2)和42年(患者3)的患者的病例报告。这些患者具备已被证明与改善长期生存相关的特征:年轻时开始血液透析、无糖尿病以及体重相对较低且稳定且营养状况良好。尽管他们都经历了长期血液透析治疗的并发症,但他们(患者3)已经过上,或者(患者1和患者2)仍在过着独立而充实的生活。他们的血液透析处方包括较长的治疗时间、适中的血流速度、先进的血液透析技术、血管通路手术以及由肾病学家提供的护理、对慢性肾脏病的良好整体管理,以及在发生心血管疾病时的预防措施和/或立即行动。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f55/8359961/2b42acc7192f/HDI-25-E29-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f55/8359961/2b42acc7192f/HDI-25-E29-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f55/8359961/2b42acc7192f/HDI-25-E29-g001.jpg

相似文献

1
Clinical and dialysis-related characteristics of extremely long-term hemodialysis survivors: Three case reports.长期血液透析幸存者的临床及透析相关特征:三例病例报告
Hemodial Int. 2021 Mar 21;25(3):E29-32. doi: 10.1111/hdi.12925.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
4
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
Patient Characteristics in Hemodialysis Mortality: A Comparison of Cerebro-Cardiovascular and Renal Failure Deaths in a Regional Core Hospital in Japan.血液透析死亡率中的患者特征:日本一家地区核心医院脑血管疾病和肾衰竭死亡情况的比较
Cureus. 2025 Aug 26;17(8):e91074. doi: 10.7759/cureus.91074. eCollection 2025 Aug.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
9
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.
10
The experiences of adults who are on dialysis and waiting for a renal transplant from a deceased donor: a systematic review.接受透析治疗并等待已故捐赠者肾脏移植的成年人的经历:一项系统综述。
JBI Database System Rev Implement Rep. 2015 Mar 12;13(2):169-211. doi: 10.11124/jbisrir-2015-1973.

引用本文的文献

1
The role of socio-cultural-demographics in long-term haemodialysis survival.社会文化人口统计学因素在长期血液透析患者生存中的作用。
Bioinformation. 2025 Apr 30;21(4):606-613. doi: 10.6026/973206300210606. eCollection 2025.
2
Half a century of haemodialysis: two patient journeys.半个世纪的血液透析:两位患者的历程。
Clin Kidney J. 2022 Apr 7;15(8):1622-1625. doi: 10.1093/ckj/sfac089. eCollection 2022 Aug.

本文引用的文献

1
The current and future landscape of dialysis.当前和未来的透析领域。
Nat Rev Nephrol. 2020 Oct;16(10):573-585. doi: 10.1038/s41581-020-0315-4. Epub 2020 Jul 30.
2
Nutritional Status and Dietary Management According to Hemodialysis Duration.根据血液透析时长的营养状况与饮食管理
Clin Nutr Res. 2019 Jan 29;8(1):28-35. doi: 10.7762/cnr.2019.8.1.28. eCollection 2019 Jan.
3
Cardiovascular disease in dialysis patients.透析患者的心血管疾病。
Nephrol Dial Transplant. 2018 Oct 1;33(suppl_3):iii28-iii34. doi: 10.1093/ndt/gfy174.
4
There's no place like home: 35-year patient survival on home hemodialysis.没有地方比得上家:居家血液透析患者35年的生存期
Semin Dial. 2018 May;31(3):300-304. doi: 10.1111/sdi.12660. Epub 2017 Dec 18.
5
What happens to the heart in chronic kidney disease?慢性肾病时心脏会发生什么变化?
J R Coll Physicians Edinb. 2017 Mar;47(1):76-82. doi: 10.4997/JRCPE.2017.117.
6
Sudden Cardiac Death Among Hemodialysis Patients.血液透析患者中的心脏性猝死
Am J Kidney Dis. 2017 May;69(5):684-695. doi: 10.1053/j.ajkd.2016.12.006. Epub 2017 Feb 17.
7
Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices.影响全球终末期肾病患者治疗结果的因素:肾脏替代治疗可及性、治疗方式使用及血液透析操作方面的差异
Lancet. 2016 Jul 16;388(10041):294-306. doi: 10.1016/S0140-6736(16)30448-2. Epub 2016 May 22.
8
Thirty years survivor on hemodialysis: a case report.
Saudi J Kidney Dis Transpl. 2014 Sep;25(5):1056-8. doi: 10.4103/1319-2442.139939.
9
Long-term haemodialysis survival.长期血液透析生存率。
Clin Kidney J. 2012 Apr;5(2):168-169. doi: 10.1093/ckj/sfs011.
10
Characteristics of 20-year survivors undergoing maintenance hemodialysis.接受维持性血液透析的20年存活者的特征
Ther Apher Dial. 2010 Dec;14(6):547-51. doi: 10.1111/j.1744-9987.2010.00846.x.